A2V.F Zhejiang Taimei Medical Technology Co., Ltd.

Healthcare Health Information Services Frankfurt Exchange
1.43 EUR
Close of Nov 11, 2026
0.3780 0.8100
Market cap
EUR 271M
P/E
-
P/B
1.84x
ROE
-3.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is A2V.F undervalued?

Graham number

The Graham number of Zhejiang Taimei Medical Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Taimei Medical Technology Co., Ltd. fundamental analysis

No fundamental analysis for Zhejiang Taimei Medical Technology Co., Ltd. yet.

Zhejiang Taimei Medical Technology Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Taimei Medical Technology Co., Ltd.

Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, e…

Full company profile